At Abbott, we're committed to helping people live their best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world – in nutrition, diagnostics, medical devices and branded generic pharmaceuticals – that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
At Terumo Interventional Systems, we constantly work to refine and perfect our products so that interventionalists can do more. That is why we support great thinking that pushes back the boundaries of our field. We are committed to innovation that embraces intricacies and complexities. Our exceptional tools and education programs empower physicians with the confidence they need to perform ever-more challenging procedures and spark progress.
As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic and economic expertise to address the complex challenges faced by healthcare systems today. Let’s take healthcare Further, Together. Learn more at www.medtronic.eu
Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting
Los Angeles – September 18, 2017- Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company will be a sponsor of the XIII European Bifurcation Club (www.bifurc.net) meeting at the Casa Das Artes in Porto, Portugal on Friday, October 13th and Saturday, October 14th, 2017. Dr. Mehran Khorsandi, the Company’s co-founder, chairman and chief medical officer will make a presentation entitled "Bifurcations Made Easy" at the conference.
“Our platform based technology is unlike anything on the market today. We have put extensive patent protection in place and are working with key institutions and KOL’s to advance our program as we move forward to commercialize the technology and pursue regulatory approval,” commented CEO Charles Laverty.
Advanced Bifurcation Systems, through its novel Mother/Daughter (“MD”) platform, has complete coverage for all lesions regardless of branch angle, size, plaque burden or location. This single system addresses both the main and side branch, and is mechanically fail-safe and self-aligning for perfect placement.
Dr. Mehran Khorsandi, commented, “We have really worked hard to perfect our technology and believe that when we commercialize our product more interventional cardiologists will be comfortable doing complex bifurcations. Our unique technology enables assembly of a bifurcating stent at the carina, regardless of angles, sizes or plaque burden. We expect that our platform, which has been tested in 10 patients to date, will require limited training, greatly reduce procedure times and improve clinical outcomes.”
About Advanced Birfurcation Systems
Advanced Bifurcation Systems (“ABS”) is a clinical stage medical device company developing an innovative stenting platform for simple treatment of all bifurcation lesions in coronary angioplasties. ABS has developed a novel technology which overcomes the limitations of current approaches while simplifying the procedure. The Company’s groundbreaking system consists of numerous differentiating features, including a unique modular independently movable dual-catheter system for provisional side-branch stenting as well as full bifurcation stenting with a proprietary crimping technology allowing for partial crimping of the main stent. For more information, go to www.advancedbifurcation.com .
About EBC 2017
The European Bifurcation Club is an organization of European thought leaders in the treatment of coronary bifurcation lesions. The group holds an annual meeting to interact with the medical industry on the development of new concepts, processes and devices as well as to give scientific credibility to new clinical and technological projects.
Advanced Birfurcation Systems
Chief Executive Officer